首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   10334篇
  免费   20篇
  国内免费   39篇
系统科学   38篇
丛书文集   69篇
教育与普及   30篇
理论与方法论   24篇
现状及发展   3999篇
研究方法   522篇
综合类   5543篇
自然研究   168篇
  2012年   151篇
  2011年   325篇
  2010年   60篇
  2009年   54篇
  2008年   168篇
  2007年   211篇
  2006年   192篇
  2005年   214篇
  2004年   210篇
  2003年   190篇
  2002年   205篇
  2001年   429篇
  2000年   440篇
  1999年   294篇
  1996年   52篇
  1994年   269篇
  1992年   252篇
  1991年   201篇
  1990年   230篇
  1989年   192篇
  1988年   185篇
  1987年   190篇
  1986年   201篇
  1985年   264篇
  1984年   201篇
  1983年   163篇
  1982年   135篇
  1981年   140篇
  1980年   144篇
  1979年   325篇
  1978年   263篇
  1977年   215篇
  1976年   191篇
  1975年   195篇
  1974年   206篇
  1973年   176篇
  1972年   206篇
  1971年   245篇
  1970年   303篇
  1969年   229篇
  1968年   226篇
  1967年   194篇
  1966年   223篇
  1965年   149篇
  1959年   75篇
  1958年   123篇
  1957年   81篇
  1956年   58篇
  1954年   62篇
  1948年   57篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
An aerodynamic sense organ stimulating and regulating flight in locusts   总被引:2,自引:0,他引:2  
WEIS-FOGH T 《Nature》1949,164(4177):873
  相似文献   
2.
Phosphodiesterases (PDEs) are essential regulators of cyclic nucleotide signaling with diverse physiological functions. Because of their great market potential and therapeutic importance, PDE inhibitors became recognized as important therapeutic agents in the treatment of various diseases. Currently, there are seven PDE inhibitors on the market, and the pharmacological and safety evaluations of many drug candidates are in progress. Three-dimensional (3D) structures of catalytic domains of PDE 1, -3, -4, -5 and -9 in the presence of their inhibitors are now available, and can be utilized for rational drug design. Recent advances in molecular pharmacology of PDE isoenzymes resulted in identification of new potential applications of PDE inhibitors in various therapeutic areas, including dementia, depression and schizophrenia. This review will describe the latest advances in PDE research on 3D structural studies, the potential of therapeutic applications and the development of drug candidates.Received 30 November 2004; received after revision 24 January 2005; accepted 5 February 2005  相似文献   
3.
The PREPL (previously called KIAA0436) gene encodes a putative serine peptidase from the prolyl oligopeptidase family. A chromosomal deletion involving the PREPL gene leads to a severe syndrome with multiple symptoms. Homology with oligopeptidase B suggested that the enzyme cleaves after an arginine or lysine residue. Several PREPL splice variants have been identified, and a 638-residue variant (PREPL A) was expressed in Escherichia coli and purified. Its secondary structure was similar to that of oligopeptidase B, but differential-scanning calorimetry indicated a higher conformational stability. Dimerization may account for the enhanced stability. Unexpectedly, the PREPL A protein did not cleave peptide substrates containing a P1 basic residue, but did slowly hydrolyse an activated ester substrate, and reacted with diisopropyl fluorophosphate. These results indicated that the catalytic serine is a reactive residue. However, the negligible hydrolytic activity suggests that the function of PREPL A is different from that of the other members of the prolyl oligopeptidase family.  相似文献   
4.
5.
Many have hypothesized that cell death in Parkinsons disease is via apoptosis and, specifically, by the mitochondrial-mediated apoptotic pathway. We tested this hypothesis using a mouse dopaminergic cell line of mesencephalic origin, MN9D, challenged with the Parkinsonism-causing neurotoxin MPP+ (1-methyl-4-phenylpyridinium ion). Apoptosis was the main mode of cell death when the cells were subjected to MPP+ treatment under serum-free conditions for 24 h. Caspase-3 and caspase-9, however, were not activated, thus indicating the existence of alternate or compensatory cell death pathway(s) in dopaminergic neuronal cells. Using caspase inhibitors, we demonstrated that these pathways involve caspase-2, –8, –6 and –7. A time-course study indicated that activation of caspase-2 and –8 occurred upstream of caspase-6 and caspase-7. Upon MPP+ challenge, the apoptosis-inducing factor was translocated from the mitochondria into the MN9D cytosol and nucleus. These results suggest the existence of alternative apoptotic pathways in dopaminergic neurons.Received 20 September 2004; received after revision 5 November 2004; accepted 22 November 2004  相似文献   
6.
This paper uses Stafford Beer's Viable Systems Diagnosis (VSD) to suggest that the development of a model for actionable theory in organizations would take the form of a three-step process. The first step involves the definition and explanation of an appropriate theory base, the second theory interpretation into a coherent set of action principles and the third contextual action in organizations. We contend that even for a well-informed and widely read manager gleaning the theoretical basis for this process from the recognized Beer trilogy “Brain of the Firm,” “The Heart of the Enterprise” and “Diagnosing the System” is difficult to justify in terms of time, understanding, and action. We maintain that a sound set of action principles emanating from Beer's primary work must be considered before tackling the noted trilogy. We use Beer's initial text “Cybernetics and Management” to trace some fundamental operational research and the interdisciplinary tripartite science of cybernetics. We commence our action model process with some introductory thoughts into operational research, cybernetics, VSD, and contextual action. Our first step toward action involves some primary definitions and principles of cybernetic theory and the prospect of controlling overwhelming variety. Our second step provides our set of coherent potential action principles fundamental to cybernetic theory. The paper is written in a journalistic rather than academic style reflecting the need to couch the interpretation of the theory in a language that the well-informed manager may readily translate into third step contextual practice.  相似文献   
7.
生物序列分析   总被引:1,自引:0,他引:1  
T.P.Speed 《自然杂志》2002,24(5):254-258
这次演讲将回顾近 1 0多年来应用某些随机模型于生物序列分析的研究工作 .这些模型本身有很长的历史 ,可追溯到 3 0多年以前 ,尽管从那时起 ,这些模型已经产生了很多新的变种 .在生物序列分析中模型的作用是归总那些涉及到在生物信息学中已知的模体 (motif)或域 (domain)的信息 ,并且提供一种工具在另一序列片段中寻找模体或域的实例 (instance) .我们将逐步介绍模体模型 ,从非常简单的 ,非随机情况开始 ,进而是更复杂的情况 ,直至近来的关于模体的剖面隐马氏模型 .第二个例子是来自利用一个或两个物种的序列数据进行基因发现 ,其中广义隐马氏模型或广义成对 (pair)隐马氏模型已被证实非常有效  相似文献   
8.
In recent years, SmCo series thin films have been found to be good candidates for fabricating integrated electromagnetic components and ultrahigh density magnetic recording media[1,2]. Up to now,intensive studies of such films have been carried out in order to obtain appropriate microstructure, crystallographic orientation and other properties. Substitution of Cu or Ni for Co in SmCo/Cr series films leads to a decrease of the saturation magnetization, magnetic switching volume, and to an increase of uniaxial anisotropy and coercivity[3-5].Various deposition conditions have also been investigated[6]. The large increase in coercivity for the annealed SmCo/Cr films is due to the growth of crystallitest[7,8]. In this article, we report a study of the deposition process,structure, and magnetic behavior of sputtered Sm (Co,Cu, Ti)/Cr series thin films.  相似文献   
9.
    
  相似文献   
10.
    
P Asquith  J Housley  W T Cooke 《Nature》1970,228(5270):462-464
  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号